ENOSI LIFE SCIENCES
Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer. The company was founded by world-renowned scientists Professor Sir Marc Feldman in San Diego, California in 2020.
ENOSI LIFE SCIENCES
Industry:
Biotechnology Fitness Health Care Therapeutics Wellness
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.enosi-life.com
Total Employee:
1+
Status:
Active
Contact:
858-350-4392
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Berkeleylife
Berkeley Life is a wellness company focusing on cardiovascular health incorporating an app for monitoring Nitric Oxide and Blood Pressure.
BioMech Golf
BioMech Golf bases its research and development on the biological and physical sciences.
Parvus Therapeutics
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.
PatchAid
PatchAid is the result of research to develop a high-tech, matrix-style transdermal vitamin patch.
Rapid Reboot
Rapid Reboot provides a range of medical compression and electronic products as well as providing apparel and related accessories.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-09 | Enosi Life Sciences Appoints Dr. Patrick William Gray as Chief Executive Officer |
Official Site Inspections
http://www.enosi-life.com
- Host name: 16.110.212.35.bc.googleusercontent.com
- IP address: 35.212.110.16
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Enosi Life Sciences"
Enosi Life Sciences - Crunchbase Company Profile & Funding
Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer. The company was founded by world-renowned scientists …See details»
Board - Enosi Therapeutics Corporation
THE ENOSI Board Joining Forces For Progress Inspired by the Greek word enosis, or “union,” Enosi Life Sciences was born when world-renowned scientists Professor Sir Marc Feldmann …See details»
Enosi Life Sciences - VentureRadar
" Enosi Life Sciences is creating second generation, improved anti-TNF therapeutics, more precisely targeted for more effective treatment of inflammation, autoimmune diseases and …See details»
A single approach to creating effective cancer and autoimmune …
Enosi Life Sciences - Contacts, Employees, Board Members
Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Enosi Life Sciences Appoints Biotech, Pharma and Venture Capital ...
Sep 14, 2020 To learn more about Enosi Life Sciences, visit www.enosi-life.com.Company Contact Ozan Pamir, CFO Enosi Life Sciences [email protected] 858-350-4392IR Contact …See details»
Enosi Life Sciences President and CSO Dr. Michael Shepard Speaks …
EUGENE, Ore., Nov. 30, 2021 /PRNewswire/ -- Dr. Michael Shepard, President and Chief Scientific Officer of Enosi Life Sciences, a drug research and development company focused …See details»
Team - Enosi Therapeutics Corporation
Before being named Enosi Life Sciences CEO, Dr. Gray served as CEO for Pascal Biosciences (2015-2021) and was CEO of Nura, Inc. (2003-2006). Dr. Gray has had close relationships …See details»
Michael Shepard - President and CEO, Enosi-Life.com - LinkedIn
President and CEO at Enosi Life Sciences (Enosi-Life.com) · <br>A recipient of the Harvard Medical School Warren Alpert Award and the Lasker Prize for Clinical Medicine, Shepard …See details»
Enosi Life Sciences Appoints Biotech, Pharma and Venture
Sep 14, 2020 To learn more about Enosi Life Sciences, visit www.enosi-life.com. Company Contact Ozan Pamir, CFO Enosi Life Sciences [email protected] 858-350-4392. IR …See details»
Enosi Life Sciences Announces Executive Appointments as the …
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Enosi Life Sciences, a drug research and development company focused on providing industry-leading therapeutics for inflammatory …See details»
Enosi Life Sciences Launches Regulation D Offering to Fund …
Sep 29, 2020 To learn more about Enosi Life Sciences, visit www.enosi-life.com.IR Contact Chris Burke Redtail Media [email protected] Relations Contact Kate Caruso …See details»
Enosi Life Sciences Files Patent for TNF-Inhibiting - GlobeNewswire
Nov 18, 2020 Enosi Life Sciences Corp. is a drug research and development company focused on providing industry-leading therapeutics for autoimmune diseases and cancer. The company …See details»
Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules …
Nov 18, 2020 Enosi Life Sciences Corp. is a drug research and development company focused on providing industry-leading therapeutics for autoimmune diseases and cancer. The company …See details»
EN-1206-Fc - Drug Targets, Indications, Patents - Synapse - Patsnap
2 days ago Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals. Start Free …See details»
EN 3001 - AdisInsight - Springer
Nov 27, 2020 ENS 3001 is being developed by Enosi Life Sciences for the treatment of autoimmune disorders and cancer. EN 3001 molecule will counter TNFR2 activation. The EN …See details»
Enosi Life Sciences Appoints Dr. Patrick William Gray as Chief ...
Nov 9, 2021 /PRNewswire/ -- Enosi Life Sciences, ... and vision to Enosi's rapidly growing organization. Before being named Enosi Life Sciences CEO, Dr. Gray served as CEO for …See details»
Enosi Life Sciences Launches Regulation D Offering to Fund …
Capital raised from the Regulation D offering will support the continued development of Enosi’s novel “second generation” anti-TNF therapeutics SAN DIEGO, Sept. 29, 2020 (GLOBE …See details»
EN-3001 - Drug Targets, Indications, Patents - Synapse
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals. Start Free Trial Start …See details»